Navigation Links
Champions' CFO Resigns
Date:1/14/2011

BALTIMORE, Jan. 14, 2011 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced today the resignation of Mark Schonau, Champions' Chief Financial Officer. Mr. Schonau indicated that he has no disagreements with management and has resigned to pursue other opportunities. Champions is seeking chief financial officer candidates and intends to complete the search in the near future.

About Champions Biotechnology, Inc.

Champions Biotechnology, Inc. is engaged in the development of advanced translational platforms and tumor specific data to enhance and accelerate the value of oncology drugs. The Company's Technology Platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments (Champions Tumorgrafts(TM)) in a manner that preserves the biological characteristics of the original human tumor. Early studies suggest that unlike traditional xenografts, these Tumorgrafts closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients. Champions Biotechnology leverages its preclinical platform to evaluate drug candidates and to develop a portfolio of novel therapeutic candidates. As drugs progress through early stage development, the Company plans to sell, partner or license them to pharmaceutical and/or biotechnology companies, as appropriate. The Company also offers its predictive preclinical platform and tumor specific data to physicians for personalized patient care and to companies for evaluation of oncology drugs in models that integrate prognostic testing with biomarker discovery.

www.championsbiotechnol
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Champions Biotechnology Awarded $1.46 million in Grants
2. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
3. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
4. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
5. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
6. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. John A. MacPhee Resigns From Strativa Pharmaceuticals
10. Paul D. Duke Resigns From Mesas Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rd24gk/chromatography ... "Chromatography (Instruments and Reagents) Global Market - Forecast ... Chromatography is an analytical technique, a method ... complex mixture by differential movement through a two ... considered chromatography as an esoteric art, which mainly ...
(Date:5/6/2015)... 6, 2015   CEFALY Technology , the creators ... specifically authorized for use prior to the onset of ... migraine treatment at the EUROHEADPAIN - Midterm Meeting at ... Spain , from May 14-17, 2015. ... EUROHEADPAIN, a major European research project focused on migraines, ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, and revenue ... for the advanced wound care market? ... to 2025, assessing data, trends, opportunities and prospects there. ... tables, charts, and graphs covering 12 distinct submarket segments. ... the future market prospects. You will see financial results, ...
Breaking Medicine Technology:Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... technologyOCEANSIDE, N.Y., May 18 Ellman International, Inc. ... (FDA) has granted clearance to Pelleve(TM), a skin ... to moderate facial wrinkles and rhytids for skin ... clinical data demonstrating that a single treatment with ...
... Biopure Corporation (Nasdaq: BPUR ) ... has advised the U.S. Naval Medical Research Center (NMRC) by ... Biopure,s oxygen therapeutic Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under ... As previously announced, the study, "Restore Effective Survival in ...
Cached Medicine Technology:Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles 2Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles 3U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 2U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 3
(Date:5/6/2015)... Edvance360 LMS-SN , a leader in ... Software & Information Industry Association's (SIIA) 30th annual ... Learning Management Solution" category. Edvance360 LMS-SN won the ... this award seven years running, continued proof that Edvance360 ... industry. , "The honor of being a CODiE ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child ... center in Florida while under the influence of Flakka, according ... tapes released by CBS4’s Peter D’Oench records Doby distraught in ... is around one year old. The drug treatment center in ... not named. The residents polled by CBS Miami express concern ...
(Date:5/6/2015)... BC (PRWEB) May 06, 2015 ... hydrotherapy supplier, is excited to announce a new ... help reduce the industry’s carbon footprint while improving ... kits feature Eco-Flex™, the world’s first ... is a game-changer for hydrotherapists,” claims the company’s ...
(Date:5/6/2015)... 06, 2015 “ SideChef ” was featured on ... at the latest and coolest applications on the market for iOS, ... expert, conducted the app review and shared with viewers how this ... day when to be a good navigator people had to know ... now everyone is a master navigator. Well what if people could ...
(Date:5/6/2015)... 06, 2015 vcfo, a specialized consulting ... and operational support to optimize business performance and productivity, ... Lynch and Michael Scheaffer. Both Lynch and Scheaffer have ... experience. , “We are delighted to add Jack ... CEO. “Leveraging their background in financial management and leadership, ...
Breaking Medicine News(10 mins):Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2
... TUESDAY, March 1 (HealthDay News) -- Most youths who ... that should positively affect their everyday life, though the ... The researchers examined outcomes among 640 infants, children and ... Transplants were considered successful if they significantly improved vision ...
... disaster,s physical evidence is gone -- debris removed, shooter ... disaster on emergency responders and civilians involved still may ... in the chaos, is a vital component of any ... emergency preparedness planning. , Trained mental health responders ...
... , TUESDAY, March 1 (HealthDay News) -- There ... care unit patients with central lines, but the number of ... government report shows. From 2001 to 2009, the number ... central lines fell by 58 percent, the U.S. Centers for ...
... A review of more than 160 studies of human ... all else being equal happy people tend to ... The study, in the journal Applied Psychology: Health ... of the evidence linking happiness to health outcomes. Its lead ...
... , TUESDAY, March 1 (HealthDay News) -- A ... hospitals for sepsis -- a potentially life-threatening bacterial infection in ... those treated at other hospitals. Researchers analyzed data from ... sepsis between June 2004 and June 2006. In total, there ...
... of autism over the last three years, we are ... to Sir Michael Rutter, Professor of Developmental Psychopathology at ... new study, Rutter reviews the latest scientific developments in ... is available online in Springer,s Journal of Autism ...
Cached Medicine News:Health News:Study Rates Success of Corneal Transplants in Kids 2Health News:Emergency mental health lessons learned from Continental Flight 3407 disaster 2Health News:Emergency mental health lessons learned from Continental Flight 3407 disaster 3Health News:Dramatic Drop in Blood Infections Among ICU Patients: CDC 2Health News:Study: Happiness improves health and lengthens life 2Health News:Hospital Spending Doesn't Affect Sepsis Survival Rates 2
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: